PILL.CN
Price:
$0.005
Market Cap:
$194.55K
Canntab Therapeutics Limited, a phytopharmaceutical company, engages in the research and development of advanced pharmaceutical grade formulations of cannabinoids in Canada. It offers oral dosage formulations of pharmaceutical cannabis, including sustained release cannabinoid formulations and pellets, immediate release cannabidiol formulations, modified-release multi-layer cannabinoid formulations, flash-melt cannabinoid formulations, and bi-layer cannabinoid tablets for treating sleep disorders, post-traumatic stress disorder, social anxiety, addiction, arthritis, general pain, pain management and appetite loss associated with cancer treatments, and addiction treatment therapy of opioids an...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2011-05-20
Stock Exchange
CNQ
Ticker
PILL.CN
According to Canntab Therapeutics Limited’s latest financial reports and current stock price. The company's current PE Ratio is -0.06. This represents a change of -81.98% compared to the average of -0.31 of the last 4 quarters.
The mean historical PE Ratio of Canntab Therapeutics Limited over the last ten years is -9.30. The current -0.06 PE Ratio has changed -40.24% with respect to the historical average. Over the past ten years (40 quarters), PILL.CN's PE Ratio was at its highest in in the December 2016 quarter at 0.33. The PE Ratio was at its lowest in in the December 2017 quarter at -37.30.
Average
-9.30
Median
-5.46
Minimum
-53.75
Maximum
0
Discovering the peaks and valleys of Canntab Therapeutics Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.96%
Maximum Annual PE Ratio = 0
Minimum Annual Increase = -100.00%
Minimum Annual PE Ratio = -53.75
Year | PE Ratio | Change |
---|---|---|
2023 | 0 | -100.00% |
2022 | -3.46 | -54.28% |
2021 | -7.57 | -26.09% |
2020 | -10.25 | 33.99% |
2019 | -7.65 | 2.54% |
2018 | -7.46 | -86.13% |
2017 | -53.75 | 3.96% |
2015 | -1.32 | 56.23% |
2014 | -0.85 | 29.86% |
2013 | -0.65 | 442.07% |
The current PE Ratio of Canntab Therapeutics Limited (PILL.CN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.68
5-year avg
-5.79
10-year avg
-9.30
Canntab Therapeutics Limited’s PE Ratio is greater than FSD Pharma Inc. (-0.28), greater than Lotus Ventures Inc. (-0.77), greater than PreveCeutical Medical Inc. (-8.52), greater than World Class Extractions Inc. (-3.10), greater than 1933 Industries Inc. (-0.25),
Company | PE Ratio | Market cap |
---|---|---|
-0.28 | $88.58K | |
-0.77 | $899.70K | |
-8.52 | $10.80M | |
-3.10 | $3.30M | |
-0.25 | $4.90M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Canntab Therapeutics Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Canntab Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Canntab Therapeutics Limited's PE Ratio?
How is the PE Ratio calculated for Canntab Therapeutics Limited (PILL.CN)?
What is the highest PE Ratio for Canntab Therapeutics Limited (PILL.CN)?
What is the 3-year average PE Ratio for Canntab Therapeutics Limited (PILL.CN)?
What is the 5-year average PE Ratio for Canntab Therapeutics Limited (PILL.CN)?
How does the current PE Ratio for Canntab Therapeutics Limited (PILL.CN) compare to its historical average?